AIC100 - AffyImmune Therap
RG6457 - Bayer
Lynparza (olaparib) - Merck (MSD), AstraZeneca
zongertinib (BI 1810631) - Boehringer Ingelheim
https://www.mdanderson.org/cancerwise/top-5-md-anderson-abstracts-at-aacr-2025.h00-159775656.html
 
Apr 25, 2025
 
Prev Next